Alzheimer disease genetic risk factor APOE e4 and cognitive abilities in 111,739 UK Biobank participants

Donald M Lyall; Joey Ward; Stuart J Ritchie; Gail Davies; Breda Cullen; Carlos Celis; Mark E S Bailey; Jana Anderson; Jon Evans; Daniel F Mckay; Andrew M Mcintosh; Naveed Sattar; Daniel J Smith; Ian J Deary; Jill P Pell

doi:10.1093/ageing/afw068

Alzheimer disease genetic risk factor APOE e4 and cognitive abilities in 111,739 UK Biobank participants

Donald M Lyall, Joey Ward, Stuart J Ritchie, Gail Davies, Breda Cullen, Carlos Celis, Mark E S Bailey, Jana Anderson, Jon Evans, Daniel F Mckay, Andrew M Mcintosh, Naveed Sattar, Daniel J Smith, Ian J Deary, Jill P Pell

Research output: Contribution to journal › Article › peer-review

Abstract / Description of output

BACKGROUND: the apolipoprotein ( ITALIC! APOE) e4 locus is a genetic risk factor for dementia. Carriers of the e4 allele may be more vulnerable to conditions that are independent risk factors for cognitive decline, such as cardiometabolic diseases.

OBJECTIVE: we tested whether any association with ITALIC! APOEe4 status on cognitive ability was larger in older ages or in those with cardiometabolic diseases.

SUBJECTS: UK Biobank includes over 500,000 middle- and older aged adults who have undergone detailed medical and cognitive phenotypic assessment. Around 150,000 currently have genetic data. We examined 111,739 participants with complete genetic and cognitive data.

METHODS: baseline cognitive data relating to information processing speed, memory and reasoning were used. We tested for interactions with age and with the presence versus absence of type 2 diabetes (T2D), coronary artery disease (CAD) and hypertension.

RESULTS: in several instances, ITALIC! APOEe4 dosage interacted with older age and disease presence to affect cognitive scores. When adjusted for potentially confounding variables, there was no ITALIC! APOEe4 effect on the outcome variables.

CONCLUSIONS: future research in large independent cohorts should continue to investigate this important question, which has potential implications for aetiology related to dementia and cognitive impairment.

Original language	English
Pages (from-to)	511-517
Number of pages	6
Journal	Age and Ageing
Volume	45
Issue number	4
Early online date	21 Apr 2016
DOIs	https://doi.org/10.1093/ageing/afw068
Publication status	E-pub ahead of print - 21 Apr 2016

Access to Document

10.1093/ageing/afw068

RA2661 Centre for Cognitive Ageing and Cognitive Epidemiology Phase 2. Main Budget.
Deary, I., Gale, C., Holmes, M., Logie, P., Maclullich, A., Porteous, D., Seckl, J., Starr, J., Wardlaw, J. & Okely, J.
1/09/13 → 31/08/19
Project: Research

Cite this

Lyall, D. M., Ward, J., Ritchie, S. J., Davies, G., Cullen, B., Celis, C., Bailey, M. E. S., Anderson, J., Evans, J., Mckay, D. F., Mcintosh, A. M., Sattar, N., Smith, D. J., Deary, I. J., & Pell, J. P. (2016). Alzheimer disease genetic risk factor APOE e4 and cognitive abilities in 111,739 UK Biobank participants. Age and Ageing, 45(4), 511-517. https://doi.org/10.1093/ageing/afw068

@article{42862d65e5314ec587bdb1ac712928c6,

title = "Alzheimer disease genetic risk factor APOE e4 and cognitive abilities in 111,739 UK Biobank participants",

abstract = "BACKGROUND: the apolipoprotein ( ITALIC! APOE) e4 locus is a genetic risk factor for dementia. Carriers of the e4 allele may be more vulnerable to conditions that are independent risk factors for cognitive decline, such as cardiometabolic diseases.OBJECTIVE: we tested whether any association with ITALIC! APOEe4 status on cognitive ability was larger in older ages or in those with cardiometabolic diseases.SUBJECTS: UK Biobank includes over 500,000 middle- and older aged adults who have undergone detailed medical and cognitive phenotypic assessment. Around 150,000 currently have genetic data. We examined 111,739 participants with complete genetic and cognitive data.METHODS: baseline cognitive data relating to information processing speed, memory and reasoning were used. We tested for interactions with age and with the presence versus absence of type 2 diabetes (T2D), coronary artery disease (CAD) and hypertension.RESULTS: in several instances, ITALIC! APOEe4 dosage interacted with older age and disease presence to affect cognitive scores. When adjusted for potentially confounding variables, there was no ITALIC! APOEe4 effect on the outcome variables.CONCLUSIONS: future research in large independent cohorts should continue to investigate this important question, which has potential implications for aetiology related to dementia and cognitive impairment.",

author = "Lyall, {Donald M} and Joey Ward and Ritchie, {Stuart J} and Gail Davies and Breda Cullen and Carlos Celis and Bailey, {Mark E S} and Jana Anderson and Jon Evans and Mckay, {Daniel F} and Mcintosh, {Andrew M} and Naveed Sattar and Smith, {Daniel J} and Deary, {Ian J} and Pell, {Jill P}",

note = "{\textcopyright} The Author 2016. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For Permissions, please email: journals.permissions@oup.com.",

year = "2016",

month = apr,

day = "21",

doi = "10.1093/ageing/afw068",

language = "English",

volume = "45",

pages = "511--517",

journal = "Age and Ageing",

issn = "0002-0729",

publisher = "Oxford University Press",

number = "4",

}

TY - JOUR

T1 - Alzheimer disease genetic risk factor APOE e4 and cognitive abilities in 111,739 UK Biobank participants

AU - Lyall, Donald M

AU - Ward, Joey

AU - Ritchie, Stuart J

AU - Davies, Gail

AU - Cullen, Breda

AU - Celis, Carlos

AU - Bailey, Mark E S

AU - Anderson, Jana

AU - Evans, Jon

AU - Mckay, Daniel F

AU - Mcintosh, Andrew M

AU - Sattar, Naveed

AU - Smith, Daniel J

AU - Deary, Ian J

AU - Pell, Jill P

PY - 2016/4/21

Y1 - 2016/4/21

N2 - BACKGROUND: the apolipoprotein ( ITALIC! APOE) e4 locus is a genetic risk factor for dementia. Carriers of the e4 allele may be more vulnerable to conditions that are independent risk factors for cognitive decline, such as cardiometabolic diseases.OBJECTIVE: we tested whether any association with ITALIC! APOEe4 status on cognitive ability was larger in older ages or in those with cardiometabolic diseases.SUBJECTS: UK Biobank includes over 500,000 middle- and older aged adults who have undergone detailed medical and cognitive phenotypic assessment. Around 150,000 currently have genetic data. We examined 111,739 participants with complete genetic and cognitive data.METHODS: baseline cognitive data relating to information processing speed, memory and reasoning were used. We tested for interactions with age and with the presence versus absence of type 2 diabetes (T2D), coronary artery disease (CAD) and hypertension.RESULTS: in several instances, ITALIC! APOEe4 dosage interacted with older age and disease presence to affect cognitive scores. When adjusted for potentially confounding variables, there was no ITALIC! APOEe4 effect on the outcome variables.CONCLUSIONS: future research in large independent cohorts should continue to investigate this important question, which has potential implications for aetiology related to dementia and cognitive impairment.

AB - BACKGROUND: the apolipoprotein ( ITALIC! APOE) e4 locus is a genetic risk factor for dementia. Carriers of the e4 allele may be more vulnerable to conditions that are independent risk factors for cognitive decline, such as cardiometabolic diseases.OBJECTIVE: we tested whether any association with ITALIC! APOEe4 status on cognitive ability was larger in older ages or in those with cardiometabolic diseases.SUBJECTS: UK Biobank includes over 500,000 middle- and older aged adults who have undergone detailed medical and cognitive phenotypic assessment. Around 150,000 currently have genetic data. We examined 111,739 participants with complete genetic and cognitive data.METHODS: baseline cognitive data relating to information processing speed, memory and reasoning were used. We tested for interactions with age and with the presence versus absence of type 2 diabetes (T2D), coronary artery disease (CAD) and hypertension.RESULTS: in several instances, ITALIC! APOEe4 dosage interacted with older age and disease presence to affect cognitive scores. When adjusted for potentially confounding variables, there was no ITALIC! APOEe4 effect on the outcome variables.CONCLUSIONS: future research in large independent cohorts should continue to investigate this important question, which has potential implications for aetiology related to dementia and cognitive impairment.

U2 - 10.1093/ageing/afw068

DO - 10.1093/ageing/afw068

M3 - Article

C2 - 27103599

SN - 0002-0729

VL - 45

SP - 511

EP - 517

JO - Age and Ageing

JF - Age and Ageing

IS - 4

ER -

Alzheimer disease genetic risk factor APOE e4 and cognitive abilities in 111,739 UK Biobank participants

Abstract / Description of output

Access to Document

Fingerprint

Projects

RA2661 Centre for Cognitive Ageing and Cognitive Epidemiology Phase 2. Main Budget.

Cite this